Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

109 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Development of Kupffer cell targeting type-I interferon for the treatment of hepatitis via inducing anti-inflammatory and immunomodulatory actions.
Minayoshi Y, Maeda H, Yanagisawa H, Hamasaki K, Mizuta Y, Nishida K, Kinoshita R, Enoki Y, Imafuku T, Chuang VTG, Koga T, Fujiwara Y, Takeya M, Sonoda K, Wakayama T, Taguchi K, Ishima Y, Ishida T, Iwakiri Y, Tanaka M, Sasaki Y, Watanabe H, Otagiri M, Maruyama T. Minayoshi Y, et al. Among authors: iwakiri y. Drug Deliv. 2018 Nov;25(1):1067-1077. doi: 10.1080/10717544.2018.1464083. Drug Deliv. 2018. PMID: 29688069 Free PMC article.
Nitric oxide facilitates the targeting Kupffer cells of a nano-antioxidant for the treatment of NASH.
Maeda H, Ishima Y, Saruwatari J, Mizuta Y, Minayoshi Y, Ichimizu S, Yanagisawa H, Nagasaki T, Yasuda K, Oshiro S, Taura M, McConnell MJ, Oniki K, Sonoda K, Wakayama T, Kinoshita M, Shuto T, Kai H, Tanaka M, Sasaki Y, Iwakiri Y, Otagiri M, Watanabe H, Maruyama T. Maeda H, et al. Among authors: iwakiri y. J Control Release. 2022 Jan;341:457-474. doi: 10.1016/j.jconrel.2021.11.039. Epub 2021 Nov 29. J Control Release. 2022. PMID: 34856227
Digoxin improves steatohepatitis with differential involvement of liver cell subsets in mice through inhibition of PKM2 transactivation.
Zhao P, Han SN, Arumugam S, Yousaf MN, Qin Y, Jiang JX, Torok NJ, Chen Y, Mankash MS, Liu J, Li J, Iwakiri Y, Ouyang X. Zhao P, et al. Among authors: iwakiri y. Am J Physiol Gastrointest Liver Physiol. 2019 Oct 1;317(4):G387-G397. doi: 10.1152/ajpgi.00054.2019. Epub 2019 Aug 14. Am J Physiol Gastrointest Liver Physiol. 2019. PMID: 31411894 Free PMC article.
Cellular distribution of injected PLGA-nanoparticles in the liver.
Park JK, Utsumi T, Seo YE, Deng Y, Satoh A, Saltzman WM, Iwakiri Y. Park JK, et al. Among authors: iwakiri y. Nanomedicine. 2016 Jul;12(5):1365-74. doi: 10.1016/j.nano.2016.01.013. Epub 2016 Mar 4. Nanomedicine. 2016. PMID: 26961463 Free PMC article.
Is miR-21 a potent target for liver fibrosis?
Lai S, Iwakiri Y. Lai S, et al. Among authors: iwakiri y. Hepatology. 2018 Jun;67(6):2082-2084. doi: 10.1002/hep.29774. Epub 2018 Apr 19. Hepatology. 2018. PMID: 29315674 Free PMC article. No abstract available.
Lymphatics in the liver.
Tanaka M, Iwakiri Y. Tanaka M, et al. Among authors: iwakiri y. Curr Opin Immunol. 2018 Aug;53:137-142. doi: 10.1016/j.coi.2018.04.028. Epub 2018 May 14. Curr Opin Immunol. 2018. PMID: 29772409 Free PMC article. Review.
109 results